Opinion | Don’t Blame Government-Induced Drug Shortages on the Market
The Wall Street Journal· 22 小時前Prices stay artificially low and, as a result, supply is limited.
Council Post: Mitigating Operational Risk In Healthcare With High-Performance Pharmacies
Forbes· 2 日前... systems exist at the intersection of financial risk and operational risk. Amid the ... ...
...BioSciences And Mark Cuban’s Drug Company Aim To Disrupt Humira... Launch Of Yusimry At A 85 ...
Forbes· 2 日前(adalimumab). It is very likely that Yusimry (adalimumab-aqvh) will have the lowest list price among the seven Humira-referenced ...
FDA considers temporary cancer drug imports from unapproved companies to ease U.S. shortage
CNBC· 2 日前... the chemo drugs themselves rather than getting them pre-mixed. Diane Marley, 48 is a& ... ...
Factbox: US FDA approves Pfizer RSV vaccine a month after greenlighting GSK shot
Reuters· 2 日前Pfizer Inc (PFE.N) late on Wednesday received the U.S. Food and Drug Administration's ... ...
Is Merck Stock A Better Pick Over ABBV?
Forbes· 3 日前, and this valuation gap will likely narrow over time in favor of AbbVie, in our view. Looking ...
Pharmaceutical Industry Ought To Justify Drug Prices On Value, Not R&D Costs
Forbes· 3 日前The bill’s text and subsequent guidance from the Centers for Medicare and Medicaid Services lay out several explicit criteria ...
As retirement confidence drops, experts say focusing on these 4 factors can help
CNBC· 3 日前If you plan to relocate, you may want to do it early before health issues set in, he added. Alternatively, if you plan to ...
Dell TechWorld 2023 — Security, AI And Multicloud
Forbes· 3 日前In addition to catching up with old colleagues and friends, there was much news regarding Dell's strategy and vision. As ...
Takeda BrandVoice: How A Solid Financial Foundation Helps Takeda Deliver On Its Commitment To ...
Forbes· 3 日前After several years of business transformation, integration and deleveraging, we have built competitive global scale with ...